Cerus Corporation
Cerus Corporation (CERS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CERS · as of Jun 9, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
16
12 Months
Buy/Sell ratio
0.06
Buy/Sell (by trades)
Overall sentiment
Cerus Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CERS insider buying and selling by quarter
CERS insider selling · CERS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · CERS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CERS executive sell shares · CERS board member insider trading · CERS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 2, 2026 | Lucena Ann Director | Award | 60,000 | — | Form 4 |
| Jun 2, 2026 | BJERKHOLT ERIC Director | Award | 60,000 | — | Form 4 |
| Jun 2, 2026 | NACHTSHEIM JAMI K Director | Award | 60,000 | — | Form 4 |
| May 29, 2026 | Jayaraman Vivek K COO | Sale | 16,667 | $50K | Form 4 |
| Jun 2, 2026 | Witney Frank Director | Award | 60,000 | — | Form 4 |
| Jun 2, 2026 | Gregory Dean A. Director | Award | 60,000 | — | Form 4 |
| Jun 2, 2026 | Shan Hua Director | Award | 60,000 | — | Form 4 |
| May 1, 2026 | Jayaraman Vivek K COO | Sale | 16,667 | $50K | Form 4 |
| Apr 1, 2026 | Green Kevin Dennis CFO | Award | 200,000 | — | Form 4 |
| Apr 1, 2026 | Jensen Chrystal Chief Legal Officer | Award | 200,000 | — | Form 4 |
| Mar 12, 2025 | Jensen Chrystal Chief Legal Officer | Sale | 113,008 | $187K | Form 4 |
| Mar 12, 2026 | Jayaraman Vivek K COO | Sale | 165,200 | $274K | Form 4 |
| Mar 12, 2026 | Greenman William Mariner President and CEO · Director | Sale | 447,757 | $742K | Form 4 |
| Mar 12, 2026 | Green Kevin Dennis CFO | Sale | 127,544 | $211K | Form 4 |
| Mar 12, 2026 | Benjamin Richard J Chief Medical Officer | Sale | 101,740 | $169K | Form 4 |
| Mar 5, 2026 | Green Kevin Dennis CFO | Award | 63,854 | — | Form 4 |
| Mar 5, 2026 | Green Kevin Dennis CFO | Sale | 55,225 | $114K | Form 4 |
| Mar 6, 2026 | Green Kevin Dennis CFO | Sale | 27,796 | $56K | Form 4 |
| Mar 5, 2026 | Benjamin Richard J Chief Medical Officer | Award | 55,220 | — | Form 4 |
| Mar 5, 2026 | Benjamin Richard J Chief Medical Officer | Sale | 61,233 | $126K | Form 4 |
| Mar 6, 2026 | Benjamin Richard J Chief Medical Officer | Sale | 24,235 | $49K | Form 4 |
| Mar 9, 2026 | Benjamin Richard J Chief Medical Officer | Sale | 40,426 | $76K | Form 4 |
| Mar 5, 2026 | Jensen Chrystal Chief Legal Officer | Award | 55,220 | — | Form 4 |
| Mar 6, 2026 | Jensen Chrystal Chief Legal Officer | Sale | 30,845 | $62K | Form 4 |
| Mar 5, 2026 | Jayaraman Vivek K COO | Award | 80,320 | — | Form 4 |
Jensen Chrystal
Chief Legal Officer
Date
Mar 12
Shares
113,008
Price
$1.66
Value
$187K
Greenman William Mariner
President and CEO · Director
Date
Mar 12
Shares
447,757
Price
$1.66
Value
$742K
Benjamin Richard J
Chief Medical Officer
Date
Mar 12
Shares
101,740
Price
$1.66
Value
$169K
Benjamin Richard J
Chief Medical Officer
Date
Mar 5
Shares
61,233
Price
$2.06
Value
$126K
Benjamin Richard J
Chief Medical Officer
Date
Mar 6
Shares
24,235
Price
$2.01
Value
$49K
Benjamin Richard J
Chief Medical Officer
Date
Mar 9
Shares
40,426
Price
$1.88
Value
$76K
Jensen Chrystal
Chief Legal Officer
Date
Mar 6
Shares
30,845
Price
$2.01
Value
$62K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CERS insider trading
CERS insider trades
Cerus Corporation (CERS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Jayaraman Vivek K (COO), Green Kevin Dennis (CFO), Benjamin Richard J (Chief Medical Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. CERS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Cerus Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CERS insider trading · 5 questionsThe insiders of Cerus Corporation (CERS) include executives and directors such as Jayaraman Vivek K (COO), Green Kevin Dennis (CFO), Benjamin Richard J (Chief Medical Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026